MSN Group

MSN Group is a leading integrated pharmaceutical company based in Hyderabad, India, specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Founded in 2003, the company has established a robust global presence with a diverse portfolio covering over 450 APIs and 300 formulations across multiple therapeutic areas including oncology, cardiology, and nephrology. MSN Group operates state-of-the-art R&D centers and multiple USFDA-approved manufacturing facilities, positioning itself as a key player in the global generic medicine supply chain. The company is recognized for its rapid product development capabilities and extensive intellectual property portfolio, including numerous DMF and ANDA filings. With a workforce of over 14,000 professionals, MSN Group continues to expand its reach into highly regulated markets like the United States and Europe.